0001680581-18-000002.txt : 20180905 0001680581-18-000002.hdr.sgml : 20180905 20180905123221 ACCESSION NUMBER: 0001680581-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180905 DATE AS OF CHANGE: 20180905 EFFECTIVENESS DATE: 20180905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-320649 FILM NUMBER: 181054483 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001680581 Fulcrum Therapeutics, Inc. 26 Landsdowne Street CAMBRIDGE MA MASSACHUSETTS 02139 617-651-8851 DELAWARE None None Corporation true 2015 Robert Gould 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Mark Levin 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director James Geraghty 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director Alan Ezekowitz 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director James Collins 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director Kate Haviland 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director Owen Wallace 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Amit Hasija 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Executive Officer James Tananbaum 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2018-08-24 false true false 0 80000000 80000000 0 false 20 0 0 0 false Fulcrum Therapeutics, Inc. /s/ Robert Gould Robert Gould President and Chief Executive Officer 2018-08-29